We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Argue Against Release of Phase I Clinical Trial Results
Drugmakers Argue Against Release of Phase I Clinical Trial Results
March 19, 2015
The UK BioIndustry Association and EuropaBio are calling for European regulators to drop plans to release Phase I clinical trial reports, saying the information they contain is commercially sensitive.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor